AnnouncementsAbbott India: Outcome of board meeting
|Company Name||Last Price||%
|Dr Reddys Labs||2433.95||0.86||2545.00||1764.00||41,401.43|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||699,053|
|Reliance Pharma Fund (G)||395,162|
|Reliance Long Term Equity Fund (G)||223,667|
|Reliance Regular Savings Fund - Balanced Option (G)||70,271|
Abbott India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 3,166.15 crore.The company has reported a standalone sales of Rs 456.79 crore and a Net Profit of Rs 45.19 crore for the quarter ended Sep 2013.
The company management includes Munir Shaikh - Chairman, Rehan A Khan - Managing Director, Kaiyomarz Marfatia - Whole Time Director, Rajendra Shah - Independent Director, Ashok Dayal - Independent Director, Ranjan Kapur - Independent Director, Bhaskar lyer - Additional Director, Sachin Dharap - Additional Director.
It is listed on the BSE with a BSE Code of 500488 and the NSE with an NSE Code of ABBOTINDIA.
Its Registered office is at 3-4 Corporate Park, Sion -Trombay Road, Mumbai,Maharashtra - 400071.
Their Registrars are Sharepro Services (India) Pvt.Ltd.